Literature DB >> 21711339

Medical comorbidity associated with psoriasis in adults: a population-based study.

Y-W Yang1, J J Keller, H-C Lin.   

Abstract

BACKGROUND: Most publications to date on comorbidities associated with psoriasis have focused on cardiovascular and metabolic diseases. Few comprehensive investigations of medical comorbidities in a cohort of patients with psoriasis appear in the literature.
OBJECTIVES: To examine the prevalence of comorbidities in adult patients with psoriasis, including a comparison of comorbid prevalence vs. that in controls without psoriasis, in a nationally representative dataset in Taiwan.
METHODS: There were 1685 adult patients with psoriasis in the study group and 5055 randomly selected subjects in the comparison group. We used conditional logistic regression analyses to examine the risk of 29 comorbidities for these two groups after adjusting for monthly income, geographical region of residence and the level of urbanization of each patient's community of residence.
RESULTS: After adjusting for several potential confounders, patients with psoriasis had higher odds of comorbid congestive heart failure [odds ratio (OR) 1·63], ischaemic heart disease (OR 1·51), renal failure (OR 1·45), uncomplicated diabetes (OR 1·37), liver diseases (OR 1·34), hepatitis B or C (OR 1·34), complicated diabetes (OR 1·32), hyperlipidaemia (OR 1·28), hypertension (OR 1·24) and peptic ulcer (OR 1·22) than did patients without psoriasis. However, patients with mild psoriasis had higher odds of comorbidity only with uncomplicated diabetes (OR 1·55), asthma (OR 1·30), liver diseases (OR 1·30) and peptic ulcer (OR 1·26) than patients without psoriasis.
CONCLUSIONS: We conclude that psoriasis is associated with a variety of medical comorbidities including cardiovascular diseases, metabolic diseases, renal failure, liver diseases, viral hepatitis B or C, asthma and peptic ulcers.
© 2011 The Authors. BJD © 2011 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2011        PMID: 21711339     DOI: 10.1111/j.1365-2133.2011.10494.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  41 in total

1.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2015 MauiDerm Meeting.

Authors:  Seemal R Desai; Ilona J Frieden; Joel M Gelfand; Whitney High; Arthur Kavanaugh; Ashfaq A Marghoob; David M Ozog; Ted Rosen; Linda Stein Gold; Bruce Strober; Neil Swanson; George Martin
Journal:  J Clin Aesthet Dermatol       Date:  2015-09

2.  Updates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.

Authors:  George Martin; Bruce E Strober; Craig L Leonardi; Joel M Gelfand; Andrew Blauvelt; Arthur Kavanaugh; Linda Stein Gold; Brian Berman; Ted Rosen; Eggert Stockfleth
Journal:  J Clin Aesthet Dermatol       Date:  2016-09-01

Review 3.  Management of psoriasis patients with hepatitis B or hepatitis C virus infection.

Authors:  Claudio Bonifati; Viviana Lora; Dario Graceffa; Lorenzo Nosotti
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Association between psoriasis and asthma risk: A meta-analysis.

Authors:  Jian Wang; Rui Ke; Wenhua Shi; Xin Yan; Qingting Wang; Qianqian Zhang; Limin Chai; Manxiang Li
Journal:  Allergy Asthma Proc       Date:  2018-03-01       Impact factor: 2.587

5.  Psoriasis is associated with risk of obstructive sleep apnea independently from metabolic parameters and other comorbidities: a large hospital-based case-control study.

Authors:  Evangelia Papadavid; Maria Dalamaga; Katerina Vlami; Dimitra Koumaki; Sotirios Gyftopoulos; Gerasimos Socrates Christodoulatos; Spyridon Papiris; Dimitrios Rigopoulos
Journal:  Sleep Breath       Date:  2017-05-08       Impact factor: 2.816

Review 6.  Current and emerging systemic treatment strategies for psoriasis.

Authors:  Philip M Laws; Helen S Young
Journal:  Drugs       Date:  2012-10-01       Impact factor: 9.546

Review 7.  Tofacitinib: A New Oral Therapy for Psoriasis.

Authors:  Alexandra Azevedo; Tiago Torres
Journal:  Clin Drug Investig       Date:  2018-02       Impact factor: 2.859

8.  Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?

Authors:  Gamze Erfan; Savas Guzel; Seref Alpsoy; Emine N Rifaioglu; Sule Kaya; Volkan Kucukyalcın; Birol Topcu; Mustafa Kulac
Journal:  Mol Cell Biochem       Date:  2014-11-25       Impact factor: 3.396

9.  Psoriasis severity and the prevalence of major medical comorbidity: a population-based study.

Authors:  Howa Yeung; Junko Takeshita; Nehal N Mehta; Stephen E Kimmel; Alexis Ogdie; David J Margolis; Daniel B Shin; Rosemary Attor; Andrea B Troxel; Joel M Gelfand
Journal:  JAMA Dermatol       Date:  2013-10       Impact factor: 10.282

Review 10.  Cutaneous manifestations of hepatitis C in the era of new antiviral agents.

Authors:  Simone Garcovich; Matteo Garcovich; Rodolfo Capizzi; Antonio Gasbarrini; Maria Assunta Zocco
Journal:  World J Hepatol       Date:  2015-11-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.